Results 171 to 180 of about 434,626 (386)

Unravelling the Hidden and Undiagnosed Cases of Hepatitis B and C Viruses among Patients Seeking Health Care for Other Viral Illness: A Cross-Sectional Study from Central India

Indian Journal of Community Medicine
Background: Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections pose a significant global public health burden. However, a substantial proportion of individuals remain undiagnosed, forming a hidden reservoir that perpetuates onward ...
Rajeev K. Jain, Anamika Jain, Shailendra K. Jain, Deepti Chaurasia, Ankita Agarwal, Harjeet S. Maan, Swati Jain, Nagaraj Perumal, Rakesh K. Shrivastava   +8 more
doaj   +1 more source

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

New England Journal of Medicine, 2017
H. Ford, M. Bourlière, S. Gordon, S. Flamm, C. Cooper, A. Ramji, M. Tong, N. Ravendhran, J. Vierling, T. Tran, S. Pianko, M. Bansal, V. Ledinghen, R. Hyland, L. Stamm, H. Dvory‐Sobol, E. Svarovskaia, Jie Zhang, K. C. Huang, G. Subramanian, D. Brainard, J. Mchutchison, E. Verna, P. Buggisch, C. Landis, Z. Younes, M. Curry, S. Strasser, E. Schiff, K. Reddy, M. Manns, K. Kowdley, S. Zeuzem   +32 more
semanticscholar   +1 more source

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

New England Journal of Medicine, 2014
N. Afdhal, S. Zeuzem, P. Kwo, M. Chojkier, N. Gitlin, M. Puoti, M. Romero‐Gomez, J. Zarski, K. Agarwal, P. Buggisch, G. Foster, N. Bräu, M. Buti, I. Jacobson, G. Subramanian, Xiao Ding, H. Mo, Jenny C. Yang, P. Pang, W. Symonds, J. Mchutchison, A. Muir, A. Mangia, P. Marcellin   +23 more
semanticscholar   +1 more source

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn   +36 more
wiley   +1 more source

IDDF2019-ABS-0211 Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5 or 6 infection: an integrated analysis of phase 2 and 3 studies [PDF]

, 2019
Betty Yao, Tarik Asselah, Linda Frederick, Gretja Schnell, Kris V. Kowdley, Paul Y. Kwo, Fred Poordad, Kinh Van Nguyen, Samuel S. Lee   +8 more
openalex   +1 more source

HBV, HCV and HIV Seroprevalence in Syrian Refugee Patient Population Undergoing Preoperative Anaesthetic Assessment: A 10-Year Survey in a Tertiary Teaching Hospital [PDF]

, 2021
Mehmet Selim Çömez, Tayibe Bal, Mehmet Çabalak   +2 more
openalex   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source

Assessment of the Prevalence of Markers of Monoinfection with Hepatitis C Virus and Coinfection with Hepatitis C and B Viruses among the Personnel of Medical Institutions of an Endemic Region

Эпидемиология и вакцинопрофилактика
Relevance. Parenteral viral hepatitis B (HBV) and C (HCV) affect not only millions of people, but also healthcare workers due to professional contacts, which lead to the progression of liver pathology and a reduction in medical activity. Numerous studies
M. P. Kostinov, N. A. Magomedova, I. A. Khrapunova, A. V. Linok, E. Yu. Malinnikova, G. I. Alatortseva, L. N. Pritvorova, L. N. Nesterenko, I. I. Amiantova, V. V. Dotsenko, V. Yu. Kabargina, V. B. Polishchuk, M. N. Loktionova, A. A. Besshaposhnikova   +13 more
doaj   +1 more source

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.

New England Journal of Medicine, 2015
J. Feld, I. Jacobson, C. Hézode, T. Asselah, P. Ruane, N. Gruener, A. Abergel, A. Mangia, Ching‐lung Lai, H. L. Chan, F. Mazzotta, Christophe Moreno, E. Yoshida, S. Shafran, W. Towner, T. Tran, J. McNally, A. Osinusi, E. Svarovskaia, Yanni Zhu, D. Brainard, J. Mchutchison, K. Agarwal, S. Zeuzem   +23 more
semanticscholar   +1 more source

PD‐1/PD‐L1 in Hepatocellular Carcinoma (2014–2024): A Combined Macro and Micro Analysis of Immunotherapy Implications

iNew Medicine, EarlyView.
ABSTRACT Hepatocellular carcinoma (HCC) represents a significant global health issue, with the PD‐1/PD‐L1 axis serving a pivotal target for immunotherapy in this malignancy. However, a comprehensive bibliometric analysis of PD‐1/PD‐L1 research in HCC is lacking.
Xingyu Zhu, Lin Tang, Hongyan Li, Hao Li, Jiamei Wang   +4 more
wiley   +1 more source